(Q44618186)

4 December 2017

Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy (English)

1 reference

4 December 2017

0 references

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

21 March 2024

author name string

Polyxeni Koutkia

1

1 reference

4 December 2017

Gary Meininger

2

1 reference

4 December 2017

Bridget Canavan

3

1 reference

4 December 2017

Jeff Breu

4

1 reference

4 December 2017

Steven Grinspoon

5

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14559725

21 March 2024

publication date

14 October 2003

1 reference

full work available at URL

4 December 2017

https://www.physiology.org/doi/pdf/10.1152/ajpendo.00335.2003

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

American Journal of Physiology - Endocrinology and Metabolism

21 March 2024

published in

1 reference

4 December 2017

286

1 reference

4 December 2017

2

1 reference

4 December 2017

E296-303

1 reference

Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion

4 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

The influence of insulin on circulating ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Ghrelin drives GH secretion during fasting in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Metabolic basis of HIV-lipodystrophy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Analytical methods for evaluating episodic secretory activity within neuroendocrine axes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Analysis of the copulsatility of anterior pituitary hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2003

Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Assessment of abdominal fat content by computed tomography

21 March 2024

4

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity

21 March 2024

11

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution

21 March 2024

14

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.

21 March 2024

15

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

An unusual type of familial lipodystrophy

21 March 2024

18

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Interaction of free fatty acids and arginine on growth hormone secretion in man

21 March 2024

21

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

21 March 2024

22

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects

21 March 2024

25

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Ghrelin strongly stimulates growth hormone release in humans

21 March 2024

29

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay

21 March 2024

36

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00335.2003

21 March 2024

Identifiers

1 reference

4 December 2017

1 reference